A critical advance in cancer research is occurring with the use of VHH fragments to reactivate dysfunctional p53. This essential cancer suppressor protein is frequently lost in many kinds of malignancies, leading https://my-social-box.com/story7457127/nanobodies-reactivate-the-p53-protein-the-potential-hope-for-tumor-therapy